Methods and compositions for the treatment of graft failure

Details Methods and compositions for the treatment of graft failure Methods and compositions for the treatment of graft failure

A - Human Necessities

61

K

A61K 31/165 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61K 38/21 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2490989

The present invention provides methods and compositions for treating graft failure resulting from neointimal hyperplasia. These methods and compositions feature the use of platelet derived growth factor receptor (PDGFR) inhibitor compounds, such as N-phenyl-2-pyrimidine compounds (e.g., imatinib mesylate) to inhibit the biological activity of the PDGFR.

L'invention concerne des méthodes et des compositions de traitement du rejet de greffe consécutif à l'hyperplasie néointimale. Ces méthodes et compositions consistent à utiliser des composés inhibiteurs du récepteur du facteur de croissance dérivé des plaquettes (PDGFR), tels que les composés N-phényl-2-pyrimidine (par exemple, le mésylate d'imatinibe), pour inhiber l'activité biologique du PDGFR.

Affiliated with

Also associated with

Rating

Methods and compositions for the treatment of graft failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for the treatment of graft failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the treatment of graft failure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1872007